The Future of Personalized and Precision Perinatal Medicine Lucky Jain, MD, MBA  Clinics in Perinatology  Volume 42, Issue 2, Pages xvii-xix (June 2015) DOI: 10.1016/j.clp.2015.04.002 Copyright © 2015 Terms and Conditions

Fig. 1 Roadmap for the application of next generation sequencing technologies for the identification of disease-relevant genomic variations. NGS, next generation sequencing; WES, whole exome sequencing; WGS, whole exome sequencing. (Adapted from Majewski J, Schwartzentruber J, Lalonde E, et al. What can exome sequencing do for you? J Med Gen 2011;48:581; with permission.) Clinics in Perinatology 2015 42, xvii-xixDOI: (10.1016/j.clp.2015.04.002) Copyright © 2015 Terms and Conditions

Fig. 2 The course of a chronic disease over time, illustrating opportunities over time to use various molecular and clinical tools to refine risk of developing disease and interventions. (Adapted from Ginsbug GS, Willard HF. Genomic and personalized medicine: foundations and applications. Transl Res 2009;154:281; with permission.) Clinics in Perinatology 2015 42, xvii-xixDOI: (10.1016/j.clp.2015.04.002) Copyright © 2015 Terms and Conditions

Lucky Jain, MD, MBA, Consulting Editor Clinics in Perinatology 2015 42, xvii-xixDOI: (10.1016/j.clp.2015.04.002) Copyright © 2015 Terms and Conditions